Jingxing Si

1.1k total citations
31 papers, 856 citations indexed

About

Jingxing Si is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Jingxing Si has authored 31 papers receiving a total of 856 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Jingxing Si's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Jingxing Si is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Jingxing Si collaborates with scholars based in China, New Zealand and United States. Jingxing Si's co-authors include Youqing Shen, Shiqun Shao, Xiaozhou Mou, Kai Wang, Meihua Sui, Xiaoyi Chen, Jianbin Tang, Yu Cai, Xiaochen Dong and Hongqian Guo and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Macromolecules.

In The Last Decade

Jingxing Si

26 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingxing Si China 14 402 297 292 150 121 31 856
Jueun Jeon South Korea 18 482 1.2× 269 0.9× 316 1.1× 174 1.2× 91 0.8× 27 913
Rongying Zhu China 15 460 1.1× 409 1.4× 305 1.0× 204 1.4× 107 0.9× 34 1.0k
Dongsik Park South Korea 15 501 1.2× 313 1.1× 332 1.1× 181 1.2× 66 0.5× 19 1.0k
Yaohua Wei China 18 351 0.9× 326 1.1× 405 1.4× 100 0.7× 76 0.6× 32 851
Kin Man Au United States 16 366 0.9× 238 0.8× 255 0.9× 114 0.8× 210 1.7× 24 858
Gaizhen Kuang China 20 701 1.7× 319 1.1× 496 1.7× 240 1.6× 123 1.0× 42 1.2k
Lingxi Xing China 15 566 1.4× 270 0.9× 345 1.2× 274 1.8× 130 1.1× 19 945
Yu Qin China 17 525 1.3× 398 1.3× 392 1.3× 159 1.1× 131 1.1× 31 1.1k
Alexandros Marios Sofias Germany 17 505 1.3× 494 1.7× 447 1.5× 128 0.9× 135 1.1× 32 1.2k
Vijay Sagar Madamsetty United States 17 359 0.9× 464 1.6× 333 1.1× 172 1.1× 128 1.1× 31 1.1k

Countries citing papers authored by Jingxing Si

Since Specialization
Citations

This map shows the geographic impact of Jingxing Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingxing Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingxing Si more than expected).

Fields of papers citing papers by Jingxing Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingxing Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingxing Si. The network helps show where Jingxing Si may publish in the future.

Co-authorship network of co-authors of Jingxing Si

This figure shows the co-authorship network connecting the top 25 collaborators of Jingxing Si. A scholar is included among the top collaborators of Jingxing Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingxing Si. Jingxing Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yuzheng, et al.. (2025). Homogeneous porous aramid nanofiber separator as highly safe separators for lithium-sulfur batteries. Journal of Alloys and Compounds. 1039. 183063–183063. 1 indexed citations
4.
Zheng, Wenjie, Jingxing Si, Xue Yang, et al.. (2024). Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy. Acta Biomaterialia. 179. 243–255. 10 indexed citations
5.
Si, Jingxing, Jianjun He, Xiangdong Ding, et al.. (2024). Al2O3/SnC heterostructure: Physical properties, regulation effect and device design. Materials Today Communications. 39. 108670–108670. 2 indexed citations
6.
Ji, Lichen, Jingxing Si, Xiaoyan Zheng, et al.. (2024). Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancer. Journal of Colloid and Interface Science. 671. 216–231. 10 indexed citations
7.
Xia, Bing, et al.. (2024). The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189190–189190. 3 indexed citations
8.
Xu, Yuan, et al.. (2024). Role of Agrin in tissue repair and regeneration: From mechanisms to therapeutic opportunities (Review). International Journal of Molecular Medicine. 54(5). 1 indexed citations
9.
Ge, Tong, Jingxing Si, Xue Yang, et al.. (2024). Engineered Luminescent Oncolytic Vaccinia Virus Activation of Photodynamic‐Immune Combination Therapy for Colorectal Cancer. Advanced Healthcare Materials. 13(17). e2304136–e2304136. 8 indexed citations
10.
Ma, Ying‐Yu, Jingxing Si, Xiaozhou Mou, & Hai Zou. (2023). LY6E level associated with smoking as risk for lung cancer patients susceptible to COVID-19. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Fan, Mengni, Jingxing Si, Xiaogang Xu, et al.. (2021). A versatile chitosan nanogel capable of generating AgNPs in-situ and long-acting slow-release of Ag+ for highly efficient antibacterial. Carbohydrate Polymers. 257. 117636–117636. 70 indexed citations
13.
Zhang, Hongfang, Jingxing Si, Jing Yue, & Shenglin Ma. (2021). The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma. Journal of Cancer Research and Clinical Oncology. 147(5). 1275–1286. 32 indexed citations
14.
Cai, Yu, Xiaoyi Chen, Jingxing Si, Xiaozhou Mou, & Xiaochen Dong. (2021). All‐in‐One Nanomedicine: Multifunctional Single‐Component Nanoparticles for Cancer Theranostics. Small. 17(52). e2103072–e2103072. 78 indexed citations
15.
Si, Jingxing, et al.. (2020). Application of star poly(ethylene glycol) derivatives in drug delivery and controlled release. Journal of Controlled Release. 323. 565–577. 68 indexed citations
16.
Wu, Bin, Jibin Miao, Peng Chen, et al.. (2020). Interface cisplatin-crosslinked doxorubicin-loaded triblock copolymer micelles for synergistic cancer therapy. Colloids and Surfaces B Biointerfaces. 196(3). 111334–111334. 10 indexed citations
17.
Si, Jingxing, et al.. (2019). Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin. International Journal of Pharmaceutics. 568. 118499–118499. 55 indexed citations
18.
Shao, Shiqun, Quan Zhou, Jingxing Si, et al.. (2017). A non-cytotoxic dendrimer with innate and potent anticancer and anti-metastatic activities. Nature Biomedical Engineering. 1(9). 745–757. 89 indexed citations
19.
Qian, Yingying, Shoujie Chai, Zuyu Liang, et al.. (2014). KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer. Molecular Cancer. 13(1). 176–176. 47 indexed citations
20.
Shao, Shiqun, Jingxing Si, Jianbin Tang, Meihua Sui, & Youqing Shen. (2014). Jellyfish-Shaped Amphiphilic Dendrimers: Synthesis and Formation of Extremely Uniform Aggregates. Macromolecules. 47(3). 916–921. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026